Patient outcomes - ResMed Middle-East
COVID-19
Middle-East (English)
COVID-19
Close

Patient outcomes

OHS patient outcomes ResMed

 

There are many positive outcomes for OHS patients being treated with NIV:

  • Improved blood gases during the night, which in turn improves them during the day
  • Relieved ventilatory muscles1
  • Positive effect on lung function, especially when residual capacity is increased2
  • Lower mortality compared to OHS patients not treated with NIV.3

 

Special considerations

  • OHS patients require a high level of medical care, and are more likely to be hospitalized. (8.6 times higher than for general population control subjects)3
  • OHS patients have been found to make 11.2 physician visits per year compared to 5.7 visits for obese-only patients. 3
  • Effective treatment of OHS has shown a significant reduction in physician fees and a 68.4% decrease in annual hospitalization days. 3

References

  1. Contal O, Carnevale C, Borel JC, Sabil A, Tamisier R, Levy P, Janssens JP, Pepin JL. Pulse transit tima as a measure of respiratory effort under nonivasive ventilation. Eur Respir J. 2013 41(2):346-53

  • 2: Budweiser, S., Hitzl A.P., Jörres, R.A., Schmidbauer, K., Heinemann, F., Pfeifer, M., (2007). Health-related quality of life and long-term prognosis in chronic hypercapnic respiratory failure: a prospective survival analysis. Respir Res 8(17): 92

  • 3: Berg G, Delaive K, Manfreda J, et al. The use of healthcare resources in obesity hypoventilation syndrome. Chest. 2001 120: 377-383

Read more